Fresenius Medical Care (FMS) Stock
Key stats
- Market cap
- $11.53B
- Price / Earnings ratio
- 12.8x
- EPS (TTM)
- $1.69
- Volume
- Loading
- 52-week high
- $26.42
- 52-week low
- $20.02
- EPS vs analyst estimate
- +8.5%Q3 FY25 · $0.64 vs $0.59
Source: third-party data provider, as of November 13, 2026
EPS estimate: analyst consensus
Compare with FMS
Recent news

What Fresenius Medical Care AG & Co. KGaA (FMS) Said on Its Q3 Earnings Call
What Fresenius Medical Care AG & Co. KGaA (FMS) Said on Its Q3 Earnings Call
FMS

Fresenius Medical cuts top end of 2026 profit outlook
Fresenius Medical cuts top end of 2026 profit outlook
FMS

FMS Launches multiFiltratePRO System for U.S. Patients With Acute AKI
FMS Launches multiFiltratePRO System for U.S. Patients With Acute AKI
FMS

Fresenius Medical Care Reshapes China Portfolio for Long-Term Growth
Fresenius Medical Care Reshapes China Portfolio for Long-Term Growth
FMS
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 47.36
- MACD 12/26/9
- 0.17
- EMA 9 of MACD
- 0.15
- MACD histogram
- 0.02
- SMA 50
- $22.32
- Price below SMA 50
- EMA 50
- $22.55
- Price below EMA 50
- SMA 200
- $22.91
- Price below SMA 200
- EMA 200
- $22.81
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Sell
Based on 2 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $0.69 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

What Fresenius Medical Care AG & Co. KGaA (FMS) Said on Its Q3 Earnings Call
What Fresenius Medical Care AG & Co. KGaA (FMS) Said on Its Q3 Earnings Call
FMS

Fresenius Medical cuts top end of 2026 profit outlook
Fresenius Medical cuts top end of 2026 profit outlook
FMS

FMS Launches multiFiltratePRO System for U.S. Patients With Acute AKI
FMS Launches multiFiltratePRO System for U.S. Patients With Acute AKI
FMS

Fresenius Medical Care Reshapes China Portfolio for Long-Term Growth
Fresenius Medical Care Reshapes China Portfolio for Long-Term Growth
FMS

Can Fresenius Medical's 5008X Rollout Drive the Next Growth Phase?
Can Fresenius Medical's 5008X Rollout Drive the Next Growth Phase?
FMS

Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now
FMS

3 Cheap International Stocks to Buy
3 Cheap International Stocks to Buy
FMS

FMS Q2 Earnings Rise on Care Delivery, Revenues Miss, Margins Expand
FMS Q2 Earnings Rise on Care Delivery, Revenues Miss, Margins Expand
FMS

Fresenius Medical Care AG & Co. KGaA Q2 Earnings Call Highlights
Fresenius Medical Care AG & Co. KGaA Q2 Earnings Call Highlights
FMS

Dialysis firm FMC's shares slide despite earnings beat as US volumes disappoint again
Dialysis firm FMC's shares slide despite earnings beat as US volumes disappoint again
FMS
News tone: automated (AI) classification of the article's content, not a price prediction.
About Fresenius Medical Care
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Joseph E. Turk Jr. | CEO of Care Enablement & Member of Management Board | 1968 |
| Ms. Cassie McLean | CEO of Care Delivery & Member of Management Board | 1978 |
| Mr. Martin Fischer | CFO & Member of the Management Board | 1977 |
| Dr. Jorg Haring | Member of the Management Board, Global Head of Legal,Compliance & Human Resources and Labor Director | 1970 |
| Dr. Charles Hugh-Jones M.D. | Global Chief Medical Officer & Member of Management Board | 1970 |
| Dr. Dominik Heger | Executive VP and Head of Investor Relations, Strategic Development & Communications | — |
| Mr. Joachim Weith | Senior Vice President of Corporate Communications & Governmental Affairs | — |
| Dr. Gail-Suzanne Brown | Senior Vice President of Research & Development | — |
| Mr. Glenn Slater | Senior Vice President of Manufacturing and Supply Chain Operations | — |
| Dr. Wolfgang Kummerle | Senior Vice President - Quality Management International | — |
Fundamentals
Valuation
Profitability
Trading
Dividend
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 47.36
- MACD 12/26/9
- 0.17
- EMA 9 of MACD
- 0.15
- MACD histogram
- 0.02
- SMA 50
- $22.32
- Price below SMA 50
- EMA 50
- $22.55
- Price below EMA 50
- SMA 200
- $22.91
- Price below SMA 200
- EMA 200
- $22.81
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
2 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $24.00
- Average
- $24.00
- High
- $24.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -9.5 | +7.9 | ||||||||||
| 2022 | +3.7 | -6.5 | +8.0 | -8.2 | -1.1 | -15.3 | -26.2 | -6.8 | -16.9 | -2.5 | +14.1 | +2.3 |
| 2023 | +16.3 | +3.8 | +12.7 | +12.4 | -10.7 | +11.1 | +9.9 | -7.2 | -9.4 | -22.0 | +22.8 | +0.5 |
| 2024 | -9.2 | -2.3 | -0.4 | +10.2 | +0.2 | -10.2 | +3.9 | |||||
| 2025 | +0.6 | |||||||||||
| 2026 | +0.8 | +3.8 | -3.9 | +1.0 | -4.1 | +7.5 | +12.2 | -10.0 | -1.6 | +0.9 | +0.6 |
Corporate actions
Upcoming
No upcoming corporate actions for FMS



